Maria R. Wolyniak
Lodz, LD 93509, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Dynamic Assessment of Systemic Inflammatory Markers in Predicting Pathological Complete Response After Neoadjuvant Treatment in Triple-Negative Breast Cancer.
Journal: Journal of clinical medicine
Published: June 05, 2026
Liquid Biopsy-Derived microRNAs in Pancreatic Ductal Adenocarcinoma: Matrix-Specific Evidence and Translational Challenges.
Journal: International journal of molecular sciences
Published: April 19, 2026
WIN55,212-2 attenuates intestinal fibrosis in a DSS-induced mouse model.
Journal: Pharmacological reports : PR
Published: September 14, 2025
The endocannabinoid system as a therapeutic target in intestinal fibrosis.
Journal: Frontiers in pharmacology
Published: July 20, 2025
Information sharing within a social network is key to behavioral flexibility-Lessons from mice tested under seminaturalistic conditions.
Journal: Science advances
Published: January 03, 2025
Combined CB1 antagonist AM6545 and NOP agonist SCH221510 worsen DSS-induced colitis in mice.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: July 04, 2024
Modulation of CB1 and CB2 receptors and endocannabinoid activity in inflammatory bowel diseases.
Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Published: June 18, 2024
Navigating through novelties concerning mCRC treatment-the role of immunotherapy, chemotherapy, and targeted therapy in mCRC.
Journal: Frontiers in surgery
Published: March 09, 2024
A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis-Clinical Implications.
Journal: Journal of clinical medicine
Published: September 19, 2022
Targeted therapy of cognitive deficits in fragile X syndrome.
Journal: Molecular psychiatry
Published: October 16, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026